SCHEMBL6205004

SCHEMBL6205004

COC([O])c1ccccc1Br

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 3/20 0.44
CYP2C9 P11712 2/20 0.44
ALDH1A1 P00352 3/20 0.42
CYP3A4 P08684 2/20 0.42
ALOX15 P16050 2/20 0.42
IDO1 P14902 1/20 0.41
TDO2 P48775 1/20 0.41
HTT P42858 1/20 0.40
HSD11B1 P28845 1/20 0.34
KDM4E B2RXH2 2/20 0.33
MAP2K7 O14733 1/20 0.33
GMNN O75496 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
POLB P06746 1/20 0.33
CYP2D6 P10635 1/20 0.33
MAPT P10636 1/20 0.33
HPGD P15428 1/20 0.33
CDC25A P30304 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29369499 0.79 CYP2C19 (0.44) CYP2C19CYP2C9ALDH1A1CYP3A4ALOX15
SCHEMBL6325 0.79 CYP2C19 (0.44) CYP2C19CYP2C9ALDH1A1CYP3A4ALOX15
SCHEMBL29691210 0.77 CYP2C19 (0.46) CYP2C19CYP2C9ALDH1A1CYP3A4ALOX15
SCHEMBL18865623 0.77 CYP2C19 (0.46) CYP2C19CYP2C9ALDH1A1CYP3A4ALOX15
SCHEMBL6202860 0.77 ESR1 (0.52) CYP2C19CYP2C9ALDH1A1CYP3A4ALOX15
SCHEMBL6204701 0.77 GABRA1 (0.43) CYP3A4LMNACYP1A2POLBHPGD
SCHEMBL6203755 0.77 CA1 (0.52) ALDH1A1IDO1TDO2HTTKDM4E
SCHEMBL6205005 0.76 CYP2C19 (0.45) CYP2C19CYP2C9ALDH1A1CYP3A4ALOX15
SCHEMBL10992504 0.76 CYP2C19 (0.41) CYP2C19CYP2C9ALDH1A1CYP3A4ALOX15
SCHEMBL6204869 0.76 MEN1 (0.41) CYP2C9ALDH1A1CYP3A4IDO1TDO2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1668601-A N-substituted tricyclic 3-aminopyrazoles as PDFG receptor inhibitors JANSSEN PHARMACEUTICA NV (BE) 2005-09-14 CN disclosed
EP-1506175-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDGF RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2005-02-16 EP disclosed
WO-2003097609-A1 N-SUBSTITUTED TRICYCLIC 3-AMINOPYRAZOLES AS PDFG RECEPTOR INHIBITORS JANSSEN PHARMACEUTICA N.V. (BE) 2003-11-27 WO disclosed